Long-term stability of fibrinolytic factors stored at -80 °C

Thrombosis Research

Volumn 125, Issue 5, 2010, Pages 451-456

  Hernestål Boman, Jenny ^a   Jansson, Jan Håkan ^a,b   Nilsson, Torbjörn K ^c   Eliasson, Mats ^a,d   Johansson, Lars ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b Skelleftea County Hospital   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d SUNDERBY HOSPITAL   (Sweden)

Author keywords

biobank; fibrinolysis; long term storage; plasminogen activator inhibitor 1; tissue plasminogen activator

Indexed keywords

CHROMOGENIC SUBSTRATE; FIBRINOLYTIC FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 1 TISSUE PLASMINOGEN ACTIVATOR COMPLEX; REAGENT; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME MODIFICATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN STABILITY; STORAGE TEMPERATURE;

BLOOD SPECIMEN COLLECTION; DRUG STABILITY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FIBRINOLYTIC AGENTS; HUMANS; LONGITUDINAL STUDIES; REAGENT KITS, DIAGNOSTIC;

EID: 77951879470     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.12.007     Document Type: Article

References (11)

1. Lewis M.R., Callas P.W., Jenny N.S., and Tracy R.P. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 86 6 (2001 Dec) 1495-1500
2. Omran S., Hallouda M., and Essawi F. el Attar I, Aboul Enein A, Gaafar T, et al. Effect of cold storage on the haemostatic cascade systems. Transfus Sci. 17 3 (1996 Sep) 407-414
3. Woodhams B., Girardot O., Blanco M.J., Colesse G., and Gourmelin Y. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 12 4 (2001 Jun) 229-236
4. Alesci S., Borggrefe M., and Dempfle C.E. Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels. Thromb Res 124 1 (2009) 121-126
5. Hallmans G., Ågren Å., Johansson G., Stegmayr B., Jansson J., Lindahl B., et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health 31 Suppl 61 (2003) 18-24
6. Nilsson T.K., Boman K., Jansson J.H., Thøgersen A.M., Berggren M., Broberg A., et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years. Thromb Res 116 3 (2005) 249-254
7. Eliasson M., Evrin P.E., Lundblad D., Asplund K., and Rånby M. Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. Fibrinolysis 7 5 (1993) 316-323
8. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 8476 (Feb 8 1986) 307-310
9. Eksborg S. Evaluation of method-comparison data. Clin Chem 27 7 (Jul 1981) 1311-1312
10. Rånby M., Bergsdorf N., Nilsson T., Mellbring G., Winblad B., and Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 32 12 (1986 Dec) 2160-2165
11. Kluft C., and Meijer P. Update: blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop). Fibrinolysis 1996 10 (1996) 171-179